Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +47.23%
#3 Pons Pons +25.55%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +15.91%
#6 Collect on Fanable Collect on Fanable +14.24%
#7 o1.exchange o1.exchange +14.04%
#8 Ontology Gas Ontology Gas +11.63%
#9 Nockchain Nockchain +11.47%
#10 OpenGradient OpenGradient +10.61%
Coin of the day
GEKKO GEKKO
설정
언어
한국어
통화
USD
테마
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
주식 순위 #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
주가
$12.94
마지막 동기화: 2026-08-28
시가총액
$1.10B
변동 (1일)
-0.16%
변동 (1년)
-51.50%
국가
US
거래 Kolon TissueGene, Inc. (950160)

카테고리

Healthcare
Kolon TissueGene, Inc. (950160)의 주가 이력
최고 종가: $14.96 (2026-08-01 기준)

최저 종가: $50.89 (2017-11-01 기준)
Kolon TissueGene, Inc.의 주가 이력 (2017 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH